Injectable Solution Imidocarb



Each 1 mL contains,
Imidocarb dipropionate – 120 mg


Treatment of babesiosis and anaplasmosis produced by: Babesia bovis, Babesia bigemina, Babesiaequi, Babesia caballi, Babesia canis, Anaplasma sp., Anaplasma marginale.Chemoprophylactic control of babesiosis when moving animals from clean areas to endemic areas of babesiosis and anaplasmosis.


The safety and effectiveness of imidocarb has not been determined in puppies or in breeding, lactating or pregnant animals. Risk versus benefits should be considered before using this drug in dogs with impaired lung, liver or kidney function.

Withdrawal time:

Animals must not be slaughtered for human consumption until a period of at least 90 days from the last administration has passed. Milk intended for human consumption must not be taken during treatment.


Cattle and dogs: Subcutaneously behind the shoulder
Horses: Intramuscular.

Cattle: 1.0 ml/100 Kg (Equivalent to 1.2 mg/Kg
Horses: 2.0 ml/100 Kg (Equivalent to 2.4 mg/Kg)
Dogs: 0.5 ml/20 Kg (Equivalent to 3 mg/Kg)

Cattle: 2.5 ml/100 Kg (Equivalent to 3 mg/Kg)

Cattle: 2.5 ml/100 Kg (Equivalent to 3 mg/Kg)

Cattle: 2.5 ml/100 Kg (Equivalent to 3 mg/Kg
Horses: 2.0 ml/100 Kg (Equivalent to 24 mg/Kg)
Usually, a single dose of Imidocarb-LH is required, although the treatment of infections on horses may require 2 doses with an interval of 48 hours. When animals free of Babesiosis are moved to endemic areas.

Pack sizes:

10 mL, 50 mL and 100 mL



pdf pdf

Categories: , ,